ESC 365 - Development and validation of the MADIT-ICD benefit risk score for Japanese patients - from Nippon Storm study

ESC Professional Premium Access

Development and validation of the MADIT-ICD benefit risk score for Japanese patients - from Nippon Storm study

Session: New insights and management of ventricular arrhythmias in coronary artery disease

Topic: Device Treatment

Speaker: Associate Professor Y. Kondo (Chiba, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Yusuke Kondo

Chiba University Graduate School of Medicine, Chiba (Japan)

1 follower

6 more presentations in this session

Development and validation of the RISE-APOCALYPSE-VT risk score for predicting ventricular tachycardia/fibrillation in AMI

Speaker: Doctor K. Fierros-Chable (Mexico City, MX)

Impact of coronary chronic total occlusion revascularization on ventricular arrhythmias and cardiac death: a systematic review and meta-analysis

Speaker: Mr S. Su (Beijing, CN)

The impact of new-onset ventricular arrhythmias on prognosis after percutaneous coronary intervention

Speaker: Mr S. Su (Beijing, CN)

Effect of glucagon-like peptide-1 agonists on ventricular tachycardia ablation outcomes

Speaker: Doctor D. Zhang (Stony Brook, US)

Catheter ablation versus antiarrhythmic drugs in patients with ventricular tachycardia and ischemic cardiomyopathy: a meta-analysis of randomized controlled trials

Speaker: Mr D. Abraham (Manaus, BR)

Access the full session

New insights and management of ventricular arrhythmias in coronary artery disease

Speakers: Associate Professor Y. Kondo, Doctor K. Fierros-Chable, Mr S. Su, Mr S. Su, Doctor D. Zhang...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources